#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Microscopic polyangiitis Huntington's disease Ocular lymphoma Thrombocytopenia Eosinophilic granulomatosis with polyangiitis Angelman's syndrome Arteriovenous malformation Adrenocortical carcinoma Kearns-Sayre syndrome Thrombotic thrombocytopenic purpura Angiosarcoma recurrent Obliterative bronchiolitis Endometrial cancer Transitional cell carcinoma Bile acid synthesis disorder More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid Focal segmental glomerulosclerosis – Treatment Synovial sarcoma metastatic – Diagnostics Primary immunodeficiency syndrome – Diagnostics Lymphangiosarcoma – Treatment Tuberous sclerosis complex – Basic Information Breast angiosarcoma metastatic – Trials in Disease Primary hyperoxaluria – Basic Information Malignant fibrous histiocytoma – Treatment Cystic fibrosis lung – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tavapadon Cetirizine Lactose Monohydrate Azd0901 ALLO-QUADCAR01-T Quinine Dihydrochloride Suxamethonium Chloride Isaralgagene Civaparvovec AMODIAQUINE Furosemide Ph. Eur. Mk-1167 Tetracaine Hydrochloride Nms-03592088 Avatrombopag ENSIFENTRINE Bms-986458 Tulmimetostat Sufentanil Citrate Zolbetuximab Basiliximab More therapies…

    Learn about Your Condition

    Uterine leiomyosarcoma Schizophreniform disorder Toxic epidermal necrolysis Acquired haemophilia Partial lipodystrophy Anxiety Androgenetic alopecia Polymyalgia rheumatica Desmoplastic melanoma Herpes simplex meningitis Peyronie's disease Intracranial calcification Diabetic autonomic neuropathy Huntington's disease Papulopustular rosacea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pancreatic carcinoma metastatic

  • A Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Cachexia
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Ponsegromab
    Belgium Bulgaria France Germany Italy Poland +2

  • Study of M9140 for Patients With Advanced Pancreatic Cancer

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Austria France Germany Italy Spain

  • Study on Chemotherapy with Liposomal Irinotecan, Oxaliplatin, and 5-Fluorouracil for Patients with Pancreatic Cancer Spread to the Liver

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Irinotecan
    • Fluorouracil
    • Folinic Acid
    Germany

  • Study of Irinotecan with S1 or 5-Fluorouracil for Patients with Metastatic Pancreatic Cancer After Gemcitabine Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Gimeracil
    • Oteracil
    • Tegafur
    Austria Italy The Netherlands Spain

  • Study on Napabucasin, Paclitaxel, and Gemcitabine for Patients with Metastatic Pancreatic Cancer After Chemotherapy Failure

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Napabucasin
    • Gemcitabine
    • Paclitaxel
    France Spain

  • Study on Dostarlimab, Vitamin D3, and Drug Combination for Untreated Metastatic Pancreatic Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    • Pancreatic carcinoma
    Investigated Drugs:
    • Dostarlimab
    • Colecalciferol
    • Fluorouracil
    France
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!